NCT03320811View on ClinicalTrials.gov

Interpretation of Serological Tests in the Diagnosis of Celiac Disease: Anti-deamidated Gliadin Peptide Antibodies Revisited

CompletedOBSERVATIONAL
Enrollment

2,026

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

September 1, 2015

Study Completion Date

January 1, 2016

Conditions
Celiac Disease
Interventions
OTHER

Data record

Trial Locations (1)

Unknown

Damien JOLLY, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER

NCT03320811 - Interpretation of Serological Tests in the Diagnosis of Celiac Disease: Anti-deamidated Gliadin Peptide Antibodies Revisited | Biotech Hunter | Biotech Hunter